dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Quinet, Grégoire |
dc.contributor.author | Xolalpa, Wendy |
dc.contributor.author | Reyes Garau, Diana |
dc.contributor.author | Profitós-Pelejà, Núria |
dc.contributor.author | Azkargorta, Mikel |
dc.contributor.author | Ceccato, Laurie |
dc.contributor.author | Bosch Albareda, Francesc |
dc.date.accessioned | 2022-07-20T07:36:41Z |
dc.date.available | 2022-07-20T07:36:41Z |
dc.date.issued | 2022-02-12 |
dc.identifier.citation | Quinet G, Xolalpa W, Reyes-Garau D, Profitós-Pelejà N, Azkargorta M, Ceccato L, et al. Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma. Cancers. 2022 Feb 12;14(4):923. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/7853 |
dc.description | Apoptosi; Autofàgia; Inhibidor del proteasoma |
dc.description.sponsorship | This work was supported at early stages by Spanish MINECO, CTQ2011–27874 grant. M.G.-S. is a fellow of the UbiCODE project funded by the EU’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 765445. M.S.R. and L.C. were also funded by the Institut National du Cancer, France (PLBIO16-251), CONACyT-SRE (Mexico) grant 0280365 and the REPERE program of Occitanie. O.C. is funded by “La Ligue contre le cancer du Gard”. ICFO authors were supported by funding from the Spanish MINECO “Severo Ochoa” program for Centres of Excellence in R&D (CEX2019-000910-S [MCIN/ AEI/10.13039/501100011033]), from Fundació Privada Cellex, Fundación Mig-Puig, from Generalitat de Catalunya CERCA program and from LASERLAB Europe (grant agreement No 871124;). G.R. was financially supported by Fondo de Investigación Sanitaria PI15/00102 and PI18/01383, European Regional Development Fund (ERDF) ‘Una manera de hacer Europa’. G.R. and D.R.G. are members of the Spanish Network of Excellence UBIRed funded by the Spanish Ministry Science, Innovation and Universities (SAF2017-90900-REDT). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;14(4) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Sistema limfàtic - Càncer - Tractament |
dc.subject | Enzims proteolítics - Inhibidors |
dc.subject.mesh | Lymphoma, Mantle-Cell |
dc.subject.mesh | /drug therapy |
dc.title | Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers14040923 |
dc.subject.decs | linfoma de células del manto |
dc.subject.decs | /farmacoterapia |
dc.relation.publishversion | https://doi.org/10.3390/cancers14040923 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Quinet G, Ceccato L] Laboratoire de Chimie de Coordination (LCC) CNRS-UPR8241, UPS, Toulouse, France. [Xolalpa W] Proteomics Unit, CIC bioGUNE, Parque Tecnológico de Bizkaia, Derio, Spain. [Reyes-Garau D, Profitós-Pelejà N] Lymphoma Translational Group, UBIRed, Josep Carreras Leukaemia Research Institute, Badalona, Spain. [Azkargorta M] Proteomics Platform CICbioGUNE, Basque Research and Technology Alliance (BRTA), CIBERehd, ProteoRed-ISCIII, Parque Tecnológico de Bizkaia, Derio, Spain. [Bosch F] Laboratory of Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35205670 |
dc.identifier.wos | 000763741100001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |